Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects

[1]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[2]  Min-Seon Kim,et al.  Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. , 2010, The Journal of clinical endocrinology and metabolism.

[3]  W. Rathmann,et al.  Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[4]  M. Fasshauer,et al.  Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes , 2008, Diabetes.

[5]  F. Ashcroft,et al.  Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. , 2006, The Journal of clinical investigation.

[6]  M. Fasshauer,et al.  Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. , 2006, Biochemical and biophysical research communications.

[7]  Eijiro Watanabe,et al.  Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.